Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 78

1.

Evaluation of five carbapenemase detection assays for Enterobacteriaceae harbouring blaKPC variants associated with ceftazidime/avibactam resistance.

Gaibani P, Lombardo D, Foschi C, Re MC, Ambretti S.

J Antimicrob Chemother. 2020 Mar 17. pii: dkaa079. doi: 10.1093/jac/dkaa079. [Epub ahead of print] No abstract available.

PMID:
32182346
2.

Impact on Mortality of a Bundle for the Management of Enterococcal Bloodstream Infection.

Bartoletti M, Tedeschi S, Scudeller L, Pascale R, Rosselli Del Turco E, Trapani F, Tumietto F, Virgili G, Marconi L, Ianniruberto S, Rinaldi M, Contadini I, Cristini F, Bussini L, Campoli C, Ambretti S, Berlingeri A, Viale P, Giannella M.

Open Forum Infect Dis. 2019 Nov 4;6(12):ofz473. doi: 10.1093/ofid/ofz473. eCollection 2019 Dec.

3.

Follow-up blood cultures are associated with improved outcome of patients with gram-negative bloodstream infections: retrospective observational cohort study.

Giannella M, Pascale R, Pancaldi L, Monari C, Ianniruberto S, Malosso P, Bussini L, Bartoletti M, Tedeschi S, Ambretti S, Lewis R, Viale P.

Clin Microbiol Infect. 2020 Jan 30. pii: S1198-743X(20)30048-3. doi: 10.1016/j.cmi.2020.01.023. [Epub ahead of print]

PMID:
32006697
4.

Effect of Alternative Pasteurization Techniques on Human Milk's Bioactive Proteins.

Aceti A, Cavallarin L, Martini S, Giribaldi M, Vitali F, Ambretti S, Zambrini V, Corvaglia L.

J Pediatr Gastroenterol Nutr. 2020 Apr;70(4):508-512. doi: 10.1097/MPG.0000000000002598.

PMID:
31880664
5.

Prognostic Utility of the New Definition of Difficult-to-Treat Resistance Among Patients With Gram-Negative Bloodstream Infections.

Giannella M, Bussini L, Pascale R, Bartoletti M, Malagrinò M, Pancaldi L, Toschi A, Ferraro G, Marconi L, Ambretti S, Lewis R, Viale P.

Open Forum Infect Dis. 2019 Dec 12;6(12):ofz505. doi: 10.1093/ofid/ofz505. eCollection 2019 Dec.

6.

Epidemiology and complications of late-onset sepsis: an Italian area-based study.

Berardi A, Sforza F, Baroni L, Spada C, Ambretti S, Biasucci G, Bolognesi S, Capretti M, Carretto E, Ciccia M, Lanari M, Pedna MF, Rizzo V, Venturelli C, Tzialla C, Lucaccioni L, Reggiani MLB.

PLoS One. 2019 Nov 22;14(11):e0225407. doi: 10.1371/journal.pone.0225407. eCollection 2019.

7.

Bloodstream infection caused by KPC-producing Klebsiella pneumoniae resistant to ceftazidime/avibactam: epidemiology and genomic characterization.

Gaibani P, Re MC, Campoli C, Viale PL, Ambretti S.

Clin Microbiol Infect. 2019 Nov 16. pii: S1198-743X(19)30610-X. doi: 10.1016/j.cmi.2019.11.011. [Epub ahead of print]

PMID:
31740422
8.

Rectal screening of carbapenemase-producing Enterobacteriaceae: a proposed workflow.

Foschi C, Gaibani P, Lombardo D, Re MC, Ambretti S.

J Glob Antimicrob Resist. 2019 Oct 19. pii: S2213-7165(19)30266-8. doi: 10.1016/j.jgar.2019.10.012. [Epub ahead of print]

9.

Genomic characterization of a Klebsiella pneumoniae ST1519 resistant to ceftazidime/avibactam carrying a novel KPC variant (KPC-36).

Gaibani P, Ambretti S, Campoli C, Viale P, Re MC.

Int J Antimicrob Agents. 2020 Jan;55(1):105816. doi: 10.1016/j.ijantimicag.2019.09.020. Epub 2019 Oct 5. No abstract available.

PMID:
31593765
10.

Screening for carriage of carbapenem-resistant Enterobacteriaceae in settings of high endemicity: a position paper from an Italian working group on CRE infections.

Ambretti S, Bassetti M, Clerici P, Petrosillo N, Tumietto F, Viale P, Rossolini GM.

Antimicrob Resist Infect Control. 2019 Aug 13;8:136. doi: 10.1186/s13756-019-0591-6. eCollection 2019. Review.

11.

Comparative serum bactericidal activity of meropenem-based combination regimens against extended-spectrum beta-lactamase and KPC-producing Klebsiella pneumoniae.

Gaibani P, Lombardo D, Bartoletti M, Ambretti S, Campoli C, Giannella M, Tedeschi S, Conti M, Mancini R, Landini MP, Re MC, Viale P, Lewis RE.

Eur J Clin Microbiol Infect Dis. 2019 Oct;38(10):1925-1931. doi: 10.1007/s10096-019-03628-6. Epub 2019 Jul 6.

PMID:
31278562
12.

First report of Methylobacterium radiotolerans bacteraemia identified by MALDI-TOF mass spectrometry.

Cordovana M, Deni A, Kostrzewa M, Abdalla M, Ambretti S.

New Microbes New Infect. 2019 Apr 10;30:100546. doi: 10.1016/j.nmni.2019.100546. eCollection 2019 Jul.

13.

Risk factors for group B streptococcus early-onset disease: an Italian, area-based, case-control study.

Berardi A, Spada C, Creti R, Ambretti S, Chiarabini R, Barozzi A, Pagano R, Sarti M, Pedna MF, Fornaciari S, Azzalli M, Dodi I, Bacchi Reggiani ML, Lanzoni A, Vaccina E, Iughetti L, Lucaccioni L.

J Matern Fetal Neonatal Med. 2019 Jul 17:1-7. doi: 10.1080/14767058.2019.1628943. [Epub ahead of print]

PMID:
31170843
14.

The impact of carbapenemase-producing Enterobacteriaceae colonization on infection risk after liver transplantation: a prospective observational cohort study.

Giannella M, Bartoletti M, Campoli C, Rinaldi M, Coladonato S, Pascale R, Tedeschi S, Ambretti S, Cristini F, Tumietto F, Siniscalchi A, Bertuzzo V, Morelli MC, Cescon M, Pinna AD, Lewis R, Viale P.

Clin Microbiol Infect. 2019 Dec;25(12):1525-1531. doi: 10.1016/j.cmi.2019.04.014. Epub 2019 Apr 27.

PMID:
31039445
15.

In vitro synergistic activity of meropenem/vaborbactam in combination with ceftazidime/avibactam against KPC-producing Klebsiella pneumoniae.

Gaibani P, Ambretti S, Viale P, Re MC.

J Antimicrob Chemother. 2019 May 1;74(5):1457-1459. doi: 10.1093/jac/dky557. No abstract available.

PMID:
30649310
16.

Risk factors for treatment failure in patients receiving β-lactam/β-lactamase inhibitor combinations for Enterobacteriaceae bloodstream infection: A retrospective, single-centre, cohort study.

Giannella M, Pascale R, Ferraro G, Toschi A, Pancaldi L, Furii F, Bartoletti M, Tedeschi S, Ambretti S, Lewis RE, Viale P.

Int J Antimicrob Agents. 2019 May;53(5):574-581. doi: 10.1016/j.ijantimicag.2019.01.005. Epub 2019 Jan 9.

PMID:
30639527
17.

A Full MALDI-Based Approach to Detect Plasmid-Encoded KPC-Producing Klebsiella pneumoniae.

Cordovana M, Kostrzewa M, Glandorf J, Bienia M, Ambretti S, Pranada AB.

Front Microbiol. 2018 Nov 23;9:2854. doi: 10.3389/fmicb.2018.02854. eCollection 2018.

18.

Impact of meropenem on Klebsiella pneumoniae metabolism.

Foschi C, Salvo M, Laghi L, Zhu C, Ambretti S, Marangoni A, Re MC.

PLoS One. 2018 Nov 15;13(11):e0207478. doi: 10.1371/journal.pone.0207478. eCollection 2018.

19.

A novel IncA plasmid carrying blaVIM-1 in a Kluyvera cryocrescens strain.

Gaibani P, Ambretti S, Scaltriti E, Cordovana M, Berlingeri A, Pongolini S, Landini MP, Re MC.

J Antimicrob Chemother. 2018 Nov 1;73(11):3206-3208. doi: 10.1093/jac/dky304. No abstract available.

PMID:
30113679
20.

Potential role of T2Candida in the management of empirical antifungal treatment in patients at high risk of candidaemia: a pilot single-centre study.

Giannella M, Paolucci M, Roncarati G, Vandi G, Pascale R, Trapani F, Bartoletti M, Tedeschi S, Ambretti S, Lewis R, Re MC, Viale P.

J Antimicrob Chemother. 2018 Oct 1;73(10):2856-2859. doi: 10.1093/jac/dky247.

PMID:
29939275
21.

Management of immunosuppressive therapy in liver transplant recipients who develop bloodstream infection.

Bartoletti M, Vandi G, Furii F, Bertuzzo V, Ambretti S, Tedeschi S, Pascale R, Cristini F, Campoli C, Morelli MC, Cescon M, Pinna AD, Viale P, Giannella M.

Transpl Infect Dis. 2018 Oct;20(5):e12930. doi: 10.1111/tid.12930. Epub 2018 Jun 13.

PMID:
29809304
22.

Colonization and infection due to carbapenemase-producing Enterobacteriaceae in liver and lung transplant recipients and donor-derived transmission: a prospective cohort study conducted in Italy.

Errico G, Gagliotti C, Monaco M, Masiero L, Gaibani P, Ambretti S, Landini MP, D'Arezzo S, Di Caro A, Parisi SG, Palù G, Vespasiano F, Morsillo F, Moro ML, Procaccio F, Ricci A, Grossi PA, Pantosti A, Nanni Costa A; SInT Collaborative Study Group.

Clin Microbiol Infect. 2019 Feb;25(2):203-209. doi: 10.1016/j.cmi.2018.05.003. Epub 2018 May 22.

23.

Bacteroides fragilis: A whole MALDI-based workflow from identification to confirmation of carbapenemase production for routine laboratories.

Cordovana M, Kostrzewa M, Sóki J, Witt E, Ambretti S, Pranada AB.

Anaerobe. 2018 Dec;54:246-253. doi: 10.1016/j.anaerobe.2018.04.004. Epub 2018 Apr 4.

PMID:
29626622
24.

Infectious meningitis/encephalitis: evaluation of a rapid and fully automated multiplex PCR in the microbiological diagnostic workup.

Piccirilli G, Chiereghin A, Gabrielli L, Giannella M, Squarzoni D, Turello G, Felici S, Vocale C, Zuntini R, Gibertoni D, Maraolo AE, Ambretti S, Lazzarotto T.

New Microbiol. 2018 Apr;41(2):118-125. Epub 2018 Apr 5.

25.

In vivo evolution of resistant subpopulations of KPC-producing Klebsiella pneumoniae during ceftazidime/avibactam treatment.

Gaibani P, Campoli C, Lewis RE, Volpe SL, Scaltriti E, Giannella M, Pongolini S, Berlingeri A, Cristini F, Bartoletti M, Tedeschi S, Ambretti S.

J Antimicrob Chemother. 2018 Jun 1;73(6):1525-1529. doi: 10.1093/jac/dky082.

PMID:
29566151
26.

Clinical application of Bruker Biotyper MALDI-TOF/MS system for real-time identification of KPC production in Klebsiella pneumoniae clinical isolates.

Gaibani P, Ambretti S, Tamburini MV, Vecchio Nepita E, Re MC.

J Glob Antimicrob Resist. 2018 Mar;12:169-170. doi: 10.1016/j.jgar.2018.01.016. Epub 2018 Feb 22. No abstract available.

PMID:
29412181
27.

Differences in the rate of carbapenem-resistant Enterobacteriaceae colonisation or Clostridium difficile infection following frontline treatment with tigecycline vs. meropenem for intra-abdominal infections.

Bartoletti M, Tedeschi S, Pascale R, Raumer L, Maraolo AE, Palmiero G, Tumietto F, Cristini F, Ambretti S, Giannella M, Lewis RE, Viale P.

Int J Antimicrob Agents. 2018 Mar;51(3):516-521. doi: 10.1016/j.ijantimicag.2018.01.010. Epub 2018 Feb 2.

PMID:
29410250
28.

Treatment duration for Escherichia coli bloodstream infection and outcomes: retrospective single-centre study.

Giannella M, Pascale R, Toschi A, Ferraro G, Graziano E, Furii F, Bartoletti M, Tedeschi S, Ambretti S, Lewis RE, Viale P.

Clin Microbiol Infect. 2018 Oct;24(10):1077-1083. doi: 10.1016/j.cmi.2018.01.013. Epub 2018 Jan 31.

29.

Characterization of an IncL/M plasmid carrying blaOXA-48 in a Klebsiella pneumoniae strain from Italy.

Gaibani P, Scaltriti E, Benni C, Pongolini S, Ambretti S, Landini MP, Viale P, Giannella M, Re MC.

New Microbiol. 2017 Oct;40(4):284-285. Epub 2017 Oct 10.

30.

In vitro interaction of ceftazidime-avibactam in combination with different antimicrobials against KPC-producing Klebsiella pneumoniae clinical isolates.

Gaibani P, Lewis RE, Volpe SL, Giannella M, Campoli C, Landini MP, Viale P, Re MC, Ambretti S.

Int J Infect Dis. 2017 Dec;65:1-3. doi: 10.1016/j.ijid.2017.09.017. Epub 2017 Sep 22.

31.

Effect of combination therapy containing a high-dose carbapenem on mortality in patients with carbapenem-resistant Klebsiella pneumoniae bloodstream infection.

Giannella M, Trecarichi EM, Giacobbe DR, De Rosa FG, Bassetti M, Bartoloni A, Bartoletti M, Losito AR, Del Bono V, Corcione S, Tedeschi S, Raffaelli F, Saffioti C, Spanu T, Rossolini GM, Marchese A, Ambretti S, Cauda R, Viscoli C, Lewis RE, Viale P, Tumbarello M; Italian Study Group on Resistant Infections of the Società Italiana Terapia Antinfettiva (ISGRI-SITA).

Int J Antimicrob Agents. 2018 Feb;51(2):244-248. doi: 10.1016/j.ijantimicag.2017.08.019. Epub 2017 Aug 24.

PMID:
28842283
32.

Infectious Diseases Team for the Early Management of Severe Sepsis and Septic Shock in the Emergency Department.

Viale P, Tedeschi S, Scudeller L, Attard L, Badia L, Bartoletti M, Cascavilla A, Cristini F, Dentale N, Fasulo G, Legnani G, Trapani F, Tumietto F, Verucchi G, Virgili G, Berlingeri A, Ambretti S, De Molo C, Brizi M, Cavazza M, Giannella M.

Clin Infect Dis. 2017 Oct 15;65(8):1253-1259. doi: 10.1093/cid/cix548.

PMID:
28605525
33.

Risk factors for recurrent carbapenem resistant Klebsiella pneumoniae bloodstream infection: a prospective cohort study.

Giannella M, Graziano E, Marconi L, Girometti N, Bartoletti M, Tedeschi S, Tumietto F, Cristini F, Ambretti S, Berlingeri A, Lewis RE, Viale P.

Eur J Clin Microbiol Infect Dis. 2017 Oct;36(10):1965-1970. doi: 10.1007/s10096-017-3020-x. Epub 2017 Jun 1.

PMID:
28567543
34.

Previous bloodstream infections due to other pathogens as predictors of carbapenem-resistant Klebsiella pneumoniae bacteraemia in colonized patients: results from a retrospective multicentre study.

Giacobbe DR, Del Bono V, Bruzzi P, Corcione S, Giannella M, Marchese A, Magnasco L, Maraolo AE, Pagani N, Saffioti C, Ambretti S, Cardellino CS, Coppo E, De Rosa FG, Viale P, Viscoli C; ISGRI-SITA (Italian Study Group on Resistant Infections of the Società Italiana Terapia Antinfettiva).

Eur J Clin Microbiol Infect Dis. 2017 Apr;36(4):663-669. doi: 10.1007/s10096-016-2843-1. Epub 2016 Dec 1.

PMID:
27909821
35.

Infectious agents after liver transplant: etiology, timeline and patients' cell-mediated immunity responses.

Chiereghin A, Petrisli E, Ravaioli M, Morelli MC, Turello G, Squarzoni D, Piccirilli G, Ambretti S, Gabrielli L, Pinna AD, Landini MP, Lazzarotto T.

Med Microbiol Immunol. 2017 Feb;206(1):63-71. doi: 10.1007/s00430-016-0485-7. Epub 2016 Oct 25.

PMID:
27783145
36.

Epidemiology and outcome of candidemia in internal medicine wards: A regional study in Italy.

Tedeschi S, Tumietto F, Giannella M, Bartoletti M, Cristini F, Cioni G, Ambretti S, Carretto E, Sambri V, Sarti M, Viale P; Emilia Romagna Candida Network.

Eur J Intern Med. 2016 Oct;34:39-44. doi: 10.1016/j.ejim.2016.08.020. Epub 2016 Aug 21.

PMID:
27553696
37.

Evaluation of Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry for Identification of KPC-Producing Klebsiella pneumoniae.

Gaibani P, Galea A, Fagioni M, Ambretti S, Sambri V, Landini MP.

J Clin Microbiol. 2016 Oct;54(10):2609-13. doi: 10.1128/JCM.01242-16. Epub 2016 Jul 13.

38.

Ease-of-use protocol for the rapid detection of third-generation cephalosporin resistance in Enterobacteriaceae isolated from blood cultures using matrix-assisted laser desorption ionization-time-of-flight mass spectrometry.

Foschi C, Compri M, Smirnova V, Denicolò A, Nardini P, Tamburini MV, Lombardo D, Landini MP, Ambretti S.

J Hosp Infect. 2016 Jun;93(2):206-10. doi: 10.1016/j.jhin.2016.02.020. Epub 2016 Mar 8.

PMID:
27105753
39.

The burden of early-onset sepsis in Emilia-Romagna (Italy): a 4-year, population-based study.

Berardi A, Baroni L, Bacchi Reggiani ML, Ambretti S, Biasucci G, Bolognesi S, Capretti MG, Carretto E, Ciccia M, Fiorini V, Fortini C, Gargano G, Pedna MF, Rizzo V, Creti R, Ferrari F; GBS Prevention Working Group Emilia-Romagna.

J Matern Fetal Neonatal Med. 2016 Oct;29(19):3126-31. doi: 10.3109/14767058.2015.1114093. Epub 2016 Jan 14.

PMID:
26515917
40.

Use of liquid chromatography-tandem mass spectrometry (LC-MS/MS) to detect carbapenemase production in Enterobacteriaceae by a rapid meropenem degradation assay.

Foschi C, Franza V, Conti M, Tamburini MV, Roncarati G, Cordovana M, Smirnova V, Patrono D, Mancini R, Landini MP, Ambretti S.

New Microbiol. 2015 Oct;38(4):571-6. Epub 2015 Oct 20.

41.

Risk factors for bloodstream infections due to colistin-resistant KPC-producing Klebsiella pneumoniae: results from a multicenter case-control-control study.

Giacobbe DR, Del Bono V, Trecarichi EM, De Rosa FG, Giannella M, Bassetti M, Bartoloni A, Losito AR, Corcione S, Bartoletti M, Mantengoli E, Saffioti C, Pagani N, Tedeschi S, Spanu T, Rossolini GM, Marchese A, Ambretti S, Cauda R, Viale P, Viscoli C, Tumbarello M; ISGRI-SITA (Italian Study Group on Resistant Infections of the Società Italiana Terapia Antinfettiva).

Clin Microbiol Infect. 2015 Dec;21(12):1106.e1-8. doi: 10.1016/j.cmi.2015.08.001. Epub 2015 Aug 14.

42.

Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study.

Tumbarello M, Trecarichi EM, De Rosa FG, Giannella M, Giacobbe DR, Bassetti M, Losito AR, Bartoletti M, Del Bono V, Corcione S, Maiuro G, Tedeschi S, Celani L, Cardellino CS, Spanu T, Marchese A, Ambretti S, Cauda R, Viscoli C, Viale P; ISGRI-SITA (Italian Study Group on Resistant Infections of the Società Italiana Terapia Antinfettiva).

J Antimicrob Chemother. 2015 Jul;70(7):2133-43. doi: 10.1093/jac/dkv086. Epub 2015 Apr 21.

PMID:
25900159
43.

Matrix-assisted laser desorption ionization-time of flight and comparative genomic analysis of M-18 group a Streptococcus strains associated with an acute rheumatic fever outbreak in northeast Italy in 2012 and 2013.

Gaibani P, Scaltriti E, Foschi C, Baggio E, Tamburini MV, Creti R, Pascucci MG, Fagioni M, Ambretti S, Comandatore F, Pongolini S, Landini MP.

J Clin Microbiol. 2015 May;53(5):1562-72. doi: 10.1128/JCM.03465-14. Epub 2015 Mar 4.

44.

Impact of a hospital-wide multifaceted programme for reducing carbapenem-resistant Enterobacteriaceae infections in a large teaching hospital in northern Italy.

Viale P, Tumietto F, Giannella M, Bartoletti M, Tedeschi S, Ambretti S, Cristini F, Gibertoni C, Venturi S, Cavalli M, De Palma A, Puggioli MC, Mosci D, Callea E, Masina R, Moro ML, Lewis RE.

Clin Microbiol Infect. 2015 Mar;21(3):242-7. doi: 10.1016/j.cmi.2014.10.020. Epub 2014 Nov 11.

45.

Klebsiella pneumoniae bloodstream infection: epidemiology and impact of inappropriate empirical therapy.

Girometti N, Lewis RE, Giannella M, Ambretti S, Bartoletti M, Tedeschi S, Tumietto F, Cristini F, Trapani F, Gaibani P, Viale P.

Medicine (Baltimore). 2014 Oct;93(17):298-309. doi: 10.1097/MD.0000000000000111. Review.

46.

Comparison between MALDI-TOF MS and FilmArray Blood Culture Identification panel for rapid identification of yeast from positive blood culture.

Paolucci M, Foschi C, Tamburini MV, Ambretti S, Lazzarotto T, Landini MP.

J Microbiol Methods. 2014 Sep;104:92-3. doi: 10.1016/j.mimet.2014.06.018. Epub 2014 Jul 4.

PMID:
25008463
47.

In vivo evolution to colistin resistance by PmrB sensor kinase mutation in KPC-producing Klebsiella pneumoniae is associated with low-dosage colistin treatment.

Cannatelli A, Di Pilato V, Giani T, Arena F, Ambretti S, Gaibani P, D'Andrea MM, Rossolini GM.

Antimicrob Agents Chemother. 2014 Aug;58(8):4399-403. doi: 10.1128/AAC.02555-14. Epub 2014 May 19.

48.

Diversity of capsular polysaccharide gene clusters in Kpc-producing Klebsiella pneumoniae clinical isolates of sequence type 258 involved in the Italian epidemic.

D'Andrea MM, Amisano F, Giani T, Conte V, Ciacci N, Ambretti S, Santoriello L, Rossolini GM.

PLoS One. 2014 May 13;9(5):e96827. doi: 10.1371/journal.pone.0096827. eCollection 2014.

49.

Epidemiology and outcomes of bloodstream infection in patients with cirrhosis.

Bartoletti M, Giannella M, Caraceni P, Domenicali M, Ambretti S, Tedeschi S, Verucchi G, Badia L, Lewis RE, Bernardi M, Viale P.

J Hepatol. 2014 Jul;61(1):51-8. doi: 10.1016/j.jhep.2014.03.021. Epub 2014 Mar 26.

PMID:
24681345
50.

In vitro activity and post-antibiotic effects of colistin in combination with other antimicrobials against colistin-resistant KPC-producing Klebsiella pneumoniae bloodstream isolates.

Gaibani P, Lombardo D, Lewis RE, Mercuri M, Bonora S, Landini MP, Ambretti S.

J Antimicrob Chemother. 2014 Jul;69(7):1856-65. doi: 10.1093/jac/dku065. Epub 2014 Mar 19.

PMID:
24648503

Supplemental Content

Loading ...
Support Center